Trending...
- Purple Heart Recipient Honored by Hall of Fame Son In Viral Tribute Sparking National Conversation on Service Fatherhood, Healing and Legacy
- Lineus Medical's SafeBreak® Vascular Added to Alliant GPO Contract
- 66% of US Bankruptcies Are Medical — So Americans Are Building Businesses That Cover Healthcare Emergencies
NEW YORK - ncarol.com -- Ponos Industries LLC ("Purchaser") announces that its previously-announced tender offer (the "Offer") to acquire up to 14,000,000 shares of common stock (the "Shares") of AT&T Inc. for $36.00 per Share (the "Offer Price"), less dividends since September 10, 2018, has been extended to 5:00 p.m., New York City time, on Friday, November 8, 2019, unless further extended or earlier terminated (the "Expiration Date"). The Offer was scheduled to expire at 5:00 p.m., New York City time, on Friday, October 11, 2019. All other terms and conditions of the Offer remain unchanged.
As of 5:00 p.m., New York City time, on Wednesday, October 10, 2019, approximately 2,000,000 Shares had been tendered and not withdrawn from the Offer.
The Offer is subject to closing conditions set forth in the Offer to Purchase, dated September 10, 2018, including the closing price of the Shares on the NYSE on the last full trading day prior to the Expiration Date exceeding the Offer Price and Purchaser obtaining financing necessary to fund Purchaser's financial obligations arising from the Offer.
This press release is for informational purposes only and is not an offer to buy or the solicitation of an offer to sell shares or any other securities. The Offer to Purchase common stock of AT&T Inc. is only being made pursuant to the Offer to Purchase and Letter of Transmittal with respect to the Offer, as such documents may be supplemented and amended from time to time. Shareholders are urged to read these materials carefully because they contain important information, included the terms and conditions of the Offer, that shareholders should consider before making any decision regarding tendering their Shares. Shareholders can obtain a copy of the Offer to Purchase and Letter of Transmittal with respect to the Offer by contacting the information agent at (888) 422-4311 OR INFOAGENT@ponoscapital.com. Copies of materials and any documentation must not be, directly or indirectly, mailed or otherwise forwarded, distributed or sent in, into or from any jurisdiction where to do so would be unlawful.
More on ncarol.com
Ponos Industries LLC is a private investment company that specializes in investing in publicly traded securities whose value it expects to appreciate over a 12-month period.
Forward Looking Statements
Statements included in this press release that are not historical facts are forward-looking statements, which involve a number of risks and uncertainties and are subject to change at any time. While Purchaser may elect to update forward-looking statements in the future, Purchaser specifically disclaims any obligation to do so, even if estimates change and, therefore, you should not rely on these forward-looking statements as representing our views as of any date subsequent to today.
As of 5:00 p.m., New York City time, on Wednesday, October 10, 2019, approximately 2,000,000 Shares had been tendered and not withdrawn from the Offer.
The Offer is subject to closing conditions set forth in the Offer to Purchase, dated September 10, 2018, including the closing price of the Shares on the NYSE on the last full trading day prior to the Expiration Date exceeding the Offer Price and Purchaser obtaining financing necessary to fund Purchaser's financial obligations arising from the Offer.
This press release is for informational purposes only and is not an offer to buy or the solicitation of an offer to sell shares or any other securities. The Offer to Purchase common stock of AT&T Inc. is only being made pursuant to the Offer to Purchase and Letter of Transmittal with respect to the Offer, as such documents may be supplemented and amended from time to time. Shareholders are urged to read these materials carefully because they contain important information, included the terms and conditions of the Offer, that shareholders should consider before making any decision regarding tendering their Shares. Shareholders can obtain a copy of the Offer to Purchase and Letter of Transmittal with respect to the Offer by contacting the information agent at (888) 422-4311 OR INFOAGENT@ponoscapital.com. Copies of materials and any documentation must not be, directly or indirectly, mailed or otherwise forwarded, distributed or sent in, into or from any jurisdiction where to do so would be unlawful.
More on ncarol.com
- Tarrytown Expocare Pharmacy Announces Strategic Leadership Appointments to Accelerate Growth and Innovation
- New Environmental Thriller "The Star Thrower" Reimagines a Classic Lesson in Individual Impact
- Summit Appoints Javier Cabeza as Data, AI, and Analytics Practice Lead
- Interview: Why I Sponsored Carson Ware - The Full Story
- March Is Skiing's Smartest Buying Window
Ponos Industries LLC is a private investment company that specializes in investing in publicly traded securities whose value it expects to appreciate over a 12-month period.
Forward Looking Statements
Statements included in this press release that are not historical facts are forward-looking statements, which involve a number of risks and uncertainties and are subject to change at any time. While Purchaser may elect to update forward-looking statements in the future, Purchaser specifically disclaims any obligation to do so, even if estimates change and, therefore, you should not rely on these forward-looking statements as representing our views as of any date subsequent to today.
Source: Ponos Capital
0 Comments
Latest on ncarol.com
- P-Wave Classics to publish Robert Bage's Hermsprong in three volumes, beginning 12 May
- Ease Auto Group Inc. & Ease Fleet Repair Service Celebrate Grand Opening Charlotte, North Carolina
- Progressive Dental & The Closing Institute Partner with Zest Dental Solutions to Elevate Full-Arch Growth and Patient Outcomes
- CCHR: While Damaging Antipsychotics Win Approval, Proven Non-Drug Alternatives Remain Ignored
- Arcuri Group Announces Long‑Term Partnership with WakeMed Health & Hospitals to Deliver Situational Awareness and De‑escalation Training
- At 25, She Became One of the Youngest AAPI Female Founders to Win One of the World's Most Prestigious Design Awards for a Lamp That Makes You Smile
- Juego Studios Extends Full-Cycle Game Development & Outsourcing Capabilities to the UAE Market
- VENUS Goes Live on CATEX Exchange As UK Financial Ltd Activates The Premier Division Of The Maya Meme's League
- Atlanta Tech Founder Seeks Clarity on Intellectual Property and Innovation Policy
- FPTower Inc. nonprofit launches coastal safety raffle fundraiser
- Purple Heart Recipient Honored by Hall of Fame Son In Viral Tribute Sparking National Conversation on Service Fatherhood, Healing and Legacy
- STEM Agent Academy Mission 01: Reclaiming Children's Curiosity from the Digital Void
- Amicly Launches as a Safety-First Social App Designed to Help People Build Real, Meaningful Friendships
- Primeindexer Google indexing platform launched by SEO Danmark APS
- Kaltra Introduces New Downward-Spraying Distribution Technology to Boost Microchannel Evaporator Performance
- Talentica Announces Winners of Multi-Agent Hackathon 2026
- Special Alert: Undervalued Opportunity: IQSTEL (N A S D A Q: IQST) Positioned for Explosive Multi-Year Growth
- Triple-Digit Growth, Strategic N A S D A Q Uplist, Plus A Scalable Healthcare Rollout Model: Stock Symbol: CDIX
- Vesica Health Receives FDA Breakthrough Device Designation for AssureMDx
- Lineus Medical's SafeBreak® Vascular Added to Alliant GPO Contract